Loading...
Healios K.K.
4593.T•JPX
Healthcare
Biotechnology
¥637.00
¥15.00(2.41%)
Healios K.K. (4593.T) Financial Performance & Income Statement Overview
Review Healios K.K. (4593.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
362.81%
↑ 362.81%
Operating Income Growth
14.12%
↑ 14.12%
Net Income Growth
-10.78%
↓ 10.78%
Operating Cash Flow Growth
35.61%
↑ 35.61%
Operating Margin
-445.24%
↓ 445.24%
Gross Margin
61.73%
↑ 61.73%
Net Profit Margin
-743.54%
↓ 743.54%
ROE
-194.87%
↓ 194.87%
ROIC
-24.55%
↓ 24.55%
Healios K.K. (4593.T) Income Statement & Financial Overview
Review Healios K.K. (4593.T) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $5.46B | $3.67B | $4.53B | $8.89B |
| Short Term Investments | $0.00 | $6.00M | $0.00 | $0.00 |
| Cash & Short Term Investments | $5.46B | $3.67B | $4.53B | $8.89B |
| Net Receivables | $114.00M | $184.00M | $123.00M | $563.00M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Assets | $433.00M | $519.00M | $421.00M | $403.00M |
| Total Current Assets | $6.01B | $4.28B | $5.08B | $9.86B |
| Property Plant & Equipment (Net) | $974.00M | $1.03B | $474.00M | $542.00M |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $4.42B | $4.42B | $4.42B | $4.42B |
| Goodwill & Intangible Assets | $4.42B | $4.42B | $4.42B | $4.42B |
| Long Term Investments | $4.28B | $4.46B | $2.77B | $2.98B |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $0.00 | $6.00M | $1.00M | $0.00 |
| Total Non-Current Assets | $9.68B | $9.92B | $7.67B | $7.95B |
| Total Assets | $15.69B | $14.19B | $12.74B | $17.81B |
| Account Payables | $252.00M | $499.00M | $187.00M | $151.00M |
| Short Term Debt | $118.00M | $117.00M | $22.00M | $4.05B |
| Tax Payables | $0.00 | $0.00 | $0.00 | $9.00M |
| Deferred Revenue | $0.00 | $89.00M | $0.00 | $0.00 |
| Other Current Liabilities | $4.66B | $2.63B | $3.76B | $2.90B |
| Total Current Liabilities | $5.03B | $3.35B | $3.97B | $7.11B |
| Long Term Debt | $2.52B | $2.55B | $2.05B | $2.05B |
| Deferred Revenue Non-Current | $0.00 | $369.00M | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $1.33B | $1.35B | $1.15B | $1.17B |
| Other Non-Current Liabilities | $4.84B | $4.50B | $3.83B | $4.22B |
| Total Non-Current Liabilities | $8.69B | $8.76B | $7.03B | $7.43B |
| Capital Lease Obligations | $0.00 | $614.00M | $22.00M | $56.00M |
| Total Liabilities | $13.71B | $12.11B | $11.006B | $14.55B |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $2.62B | $1.36B | $1.36B | $1.36B |
| Retained Earnings | -$2.02B | $543.00M | $287.00M | $1.59B |
| Accumulated Other Comprehensive Income/Loss | -$1.75B | -$1.73B | -$1.77B | $0.00 |
| Total Stockholders Equity | $1.96B | $2.06B | $1.71B | $3.24B |
| Total Equity | $1.97B | $2.08B | $1.74B | $3.27B |
| Total Liabilities & Stockholders Equity | $15.69B | $14.19B | $12.74B | $17.81B |
| Total Investments | $4.28B | $4.46B | $2.77B | $2.98B |
| Total Debt | $2.63B | $2.66B | $2.07B | $6.10B |
| Net Debt | -$2.83B | -$1.009B | -$2.46B | -$2.79B |
Healios K.K. (4593.T) Balance Sheet Analysis
Healios K.K. (4593.T) manages its money wisely, with plenty of 35.61% and -10.78% to cover its bills. The company’s long-term debts are manageable, balanced by steady -743.54%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan